no icon
no icon
amc icon

Aditya Birla Sunlife Life Pharma And Healthcare Fund Direct Growth

Equity | Sector Specific - Pharma

(NAV as of 12/04/2024)
28.19 (-1.36)

3Y Returns

17.58%

Min SIP

500

Min Lumpsum

1000

Expense Ratio

1.06%

Fund Size

585 Cr

Inception Date

10-Jul-19

Fund Manager

Dhaval Shah

Exit Load

1% on or before 30D, Nil after 30D.

Wealthzi View

Overall Fund Zi Tag

Asset Allocation

Equity

95.59%

Debt & Others

4.41%

Market Cap Allocation

Large Cap

39.94%

Mid Cap

33.85%

Small Cap

21.80%

Other Cap

4.41%

Sector Allocation

Pharmaceuticals

76.09%

Health Care

17.54%

Cash/Deposits/Margins/Treps/Repo/Swaps

2.98%

Insurance

2.27%

Retailing

0.63%

Top Ten Holdings

Sun Pharmaceutical Industries Ltd

14.46%

Cipla Ltd

8.09%

Torrent Pharmaceuticals Ltd

7.60%

Aurobindo Pharma Ltd

7.45%

Apollo Hospitals Enterprises Ltd

7.24%

Investment Objective

Investment Objective Of The Scheme Is To Provide Long Term Capital Appreciation By Investing In Equity & Equity Related Instruments Of The Companies In The Pharmaceuticals, Healthcare And Allied Sectors In India.The Scheme Does Not Guarantee/Indicate Any Returns. There Can Be No Assurance That The Schemes Objectives Will Be Achieved.

Fund House Detail

AMC Name

Aditya Birla Sun Life AMC Limited

Address

One India Bulls Centre , Tower 1, 17th Floor, Jupiter Mill Compound841, Senapati Bapat Marg, Elphinstone RoadMumbai - 400 013

BUILD WEALTH WITH CONFIDENCE

no iconno iconno iconno icon
no icon

BSE Member code: 58371

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
get on play storeget on app store

Wealthzi Investment Advisers (A division of Lime Internet Private Limited)

[CIN: U74999DL2017PTC310507] [PAN: AADCL2103M] [GSTIN: 07AADCL2103M1ZP]

[SEBI Registered Name: Lime Internet Private Limited] [SEBI RIA Registration No: INA000018133] [BASL Member ID: 2014] [Type of Registration: Non-Individual] [Validity of Registration: Perpetual] [Registered Address: Flat No. 603, 6th Floor, Kanchenjunga Building, 18 Barakhamba Road, New Delhi - 110001] [Principal Officer: Jyoti Prakash Nayak, Email: [email protected]] [Compliance Officer: Harshit Singh, Email: [email protected]] [Grievance Officer: Sahad PV, Email: [email protected]]

[SEBI Regional Office Address: Securities and Exchange Board of India, NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023, Ph: 011-69012998, Email: [email protected]]

Disclaimers:

Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Registration granted by SEBI, membership of BASL and certification from National Institute of Securities Markets (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The information is only for consumption by the client and such material should not be redistributed.